Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins

Trends in Biochemical Sciences

Volumn 36, Issue 10, 2011, Pages 501-514

  Liou, Yih Cherng ^a   Zhou, Xiao Zhen ^b   Lu, Kun Ping ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; G PROTEIN COUPLED RECEPTOR KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; ONCOPROTEIN; PEPTIDYLPROLYL ISOMERASE PIN1; PHOSPHOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN MCL 1; RETINOIC ACID RECEPTOR ALPHA; SMAD PROTEIN; STEROID RECEPTOR COACTIVATOR 3; STRESS ACTIVATED PROTEIN KINASE; TELOMERIC REPEAT BINDING FACTOR 1; TRANSCRIPTION FACTOR E2F;

AGING; ALZHEIMER DISEASE; APOPTOSIS; BREAST TUMOR; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE PROGRESSION; CONFORMATIONAL TRANSITION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; ISOMERIZATION; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; SENILE PLAQUE; TELOMERE; UPREGULATION; VIRUS REPLICATION;

AGING; GENE EXPRESSION; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; PEPTIDYLPROLYL ISOMERASE; PHOSPHOPROTEINS; PROTEIN CONFORMATION; PROTEIN STABILITY; PROTEOLYSIS; TELOMERE;

EID: 80053299231     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2011.07.001     Document Type: Review

References (144)

1. Manning G., et al. Evolution of protein kinase signaling from yeast to man. Trends Biochem. Sci. 2002, 27:514-520.
2. Pawson T., Scott J.D. Protein phosphorylation in signaling-50 years and counting. Trends Biochem. Sci. 2005, 30:286-290.
3. Lu K.P., et al. Prolyl cis-trans isomerization as a molecular timer. Nat. Chem. Biol. 2007, 3:619-629.
4. Lu K.P., Zhou X.Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:904-916.
5. Lu K.P., et al. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996, 380:544-547.
6. Lu P.J., et al. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 1999, 283:1325-1328.
7. Ranganathan R., et al. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 1997, 89:875-886.
8. Yaffe M.B. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278:1957-1960.
9. 5 dephosphorylation by the RNA polymerase II C-terminal domain phosphatase Ssu72. J. Biol. Chem. 2011, 286:5717-5726.
10. Zhou X.Z., et al. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 2000, 6:873-883.
11. Liou Y.C. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:1335-1340.
12. Liou Y.C., et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 2003, 424:556-561.
13. Lu P.J., et al. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 1999, 399:784-788.
14. Ryo A., et al. Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 2001, 3:793-801.
15. Ryo A., et al. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 2003, 12:1413-1426.
16. Wulf G.M. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 2002, 277:47976-47979.
17. Wulf G.M., et al. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 2001, 20:3459-3472.
18. Zacchi P., et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002, 419:853-857.
19. Zheng H., et al. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002, 419:849-853.
20. Lee T.H., et al. Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function. Mol. Cell 2011, 42:147-159.
21. Lu P.J., et al. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J. Biol. Chem. 2002, 277:2381-2384.
22. Ryo A., et al. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell. Biol. 2002, 22:5281-5295.
23. You H., et al. IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry. J. Cell. Biochem. 2002, 84:211-216.
24. Lee T.H., et al. Peptidyl-prolyl cis-trans isomerase Pin1 in aging, cancer and Alzheimer's disease. Expert Rev. Mol. Med. 2011, 13:e21.
25. Hershko A., Ciechanover A. Mechanisms of intracellular protein breakdown. Annu. Rev. Biochem. 1982, 51:335-364.
26. Rock K.L., et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994, 78:761-771.
27. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 2001, 70:503-533.
28. Gutierrez G.J., Ronai Z. Ubiquitin and SUMO systems in the regulation of mitotic checkpoints. Trends Biochem. Sci. 2006, 31:324-332.
29. Cdc4 ubiquitin ligase. Cell 2003, 112:243-256.
30. Balastik M., et al. Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?. Biochim. Biophys. Acta 2007, 1772:422-429.
31. Esnault S., et al. Pinning down signaling in the immune system: the role of the peptidyl-prolyl isomerase Pin1 in immune cell function. Crit. Rev. Immunol. 2008, 28:45-60.
32. Lippens G., et al. Molecular mechanisms of the phospho-dependent prolyl cis/trans isomerase Pin1. FEBS J. 2007, 274:5211-5222.
33. Yeh E.S., Means A.R. PIN1, the cell cycle and cancer. Nat. Rev. Cancer 2007, 7:381-388.
34. Bao L., et al. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 2004, 164:1727-1737.
35. Bartkova J., et al. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 1994, 57:353-361.
36. Tetsu O., McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426.
37. Diehl J.A., et al. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 1998, 12:3499-3511.
38. Diehl J.A., et al. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 1997, 11:957-972.
39. Smeal T., et al. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 1991, 354:494-496.
40. Pulikkan J.A., et al. Elevated PIN1 expression by C/EBPα-p30 blocks C/EBPα-induced granulocytic differentiation through c-Jun in AML. Leukemia 2010, 24:914-923.
41. Craig R.W. MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia 2002, 16:444-454.
42. Ding Q., et al. Degradation of Mcl-1 by β-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Mol. Cell. Biol. 2007, 27:4006-4017.
43. Ding Q., et al. Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer Res. 2008, 68:6109-6117.
44. Reineke E.L., et al. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 Cells. Mol. Cell. Biol. 2008, 28:997-1006.
45. Ryo A., et al. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. J. Cell Sci. 2003, 116:773-783.
46. Yeh E., et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 2004, 6:308-318.
47. Arnold H.K., et al. The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc. EMBO J. 2009, 28:500-512.
48. Yeh E.S., et al. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. J. Biol. Chem. 2006, 281:241-251.
49. Mark M., et al. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu. Rev. Pharmacol. Toxicol. 2006, 46:451-480.
50. Gianni M., et al. Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARα and PML-RARα. Cancer Res. 2009, 69:1016-1026.
51. Brondani V., et al. The peptidyl-prolyl isomerase Pin1 regulates phospho-Ser retinoic acid receptor α stability. Biochem. Biophys. Res. Commun. 2005, 328:6-13.
52. Reineke E.L., et al. Promyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-like growth factor-1. J. Biol. Chem. 2010, 285:9485-9492.
53. Yi P., et al. Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1). Mol. Cell. Biol. 2005, 25:9687-9699.
54. Siegel P.M., Massague J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer 2003, 3:807-821.
55. Ebisawa T., et al. Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 2001, 276:12477-12480.
56. Kavsak P., et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol. Cell 2000, 6:1365-1375.
57. Sapkota G., et al. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell 2007, 25:441-454.
58. Nakano A., et al. Pin1 down-regulates transforming growth factor-β (TGF-β) signaling by inducing degradation of Smad proteins. J. Biol. Chem. 2009, 284:6109-6115.
59. Nigg E.A. Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell Biol. 2001, 2:21-32.
60. Metaye T., et al. Pathophysiological roles of G-protein-coupled receptor kinases. Cell. Signal. 2005, 17:917-928.
61. Metaye T., et al. Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomas. J. Endocrinol. 2008, 198:101-110.
62. Peppel K., et al. Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells attenuates mitogenic signaling via G protein-coupled and platelet-derived growth factor receptors. Circulation 2000, 102:793-799.
63. Penela P., et al. G protein-coupled receptor kinase 2 (GRK2) modulation and cell cycle progression. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1118-1123.
64. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
65. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
66. Lee V.M., et al. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 2001, 24:1121-1159.
67. Lu D.C., et al. Amyloid β protein toxicity mediated by the formation of amyloid-β protein precursor complexes. Ann. Neurol. 2003, 54:781-789.
68. Pastorino L., et al. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production. Nature 2006, 440:528-534.
69. Sultana R., et al. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis. Neurobiol. Aging 2006, 27:918-925.
70. Lim J., et al. Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy. J. Clin. Invest. 2008, 118:1877-1889.
71. Lotharius J., Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 2002, 3:932-942.
72. Ryo A. Prolyl-isomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of α-synuclein inclusions. J. Biol. Chem. 2006, 281:4117-4125.
73. Blackburn E.H. Switching and signaling at the telomere. Cell 2001, 106:661-673.
74. Blasco M.A. Telomere length, stem cells and aging. Nat. Chem. Biol. 2007, 3:640-649.
75. Chong L., et al. A human telomeric protein. Science 1995, 270:1663-1667.
76. Smogorzewska A., et al. Control of human telomere length by TRF1 and TRF2. Mol. Cell. Biol. 2000, 20:1659-1668.
77. van Steensel B., de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 1997, 385:740-743.
78. Shen M., et al. Characterization and cell cycle regulation of the related human telomeric proteins Pin2 and TRF1 suggest a role in mitosis. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:13618-13623.
79. Lee T.H., et al. Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance. Nat. Cell Biol. 2009, 11:97-105.
80. Panossian L.A., et al. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol. Aging 2003, 24:77-84.
81. De Nicola F., et al. The prolyl isomerase Pin1 affects Che-1 stability in response to apoptotic DNA damage. J. Biol. Chem. 2007, 282:19685-19691.
82. Mantovani F., et al. Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol. Cell 2004, 14:625-636.
83. Peloponese J.M., et al. Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-κB. J. Virol. 2009, 83:3238-3248.
84. Skp2 ubiquitin ligase. Mol. Cell 2005, 20:9-19.
85. Zhou W., et al. Pin1 catalyzes conformational changes of Thr-187 in p27Kip1 and mediates its stability through a polyubiquitination process. J. Biol. Chem. 2009, 284:23980-23988.
86. Hunter T., Karin M. The regulation of transcription by phosphorylation. Cell 1992, 70:375-387.
87. Stukenberg P.T., Kirschner M.W. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol. Cell 2001, 7:1071-1083.
88. Kosik K.S., et al. Cellular signaling pathways and cytoskeletal organization. Ann. N. Y. Acad. Sci. 1996, 777:114-120.
89. Spillantini M.G., Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 1998, 21:428-433.
90. Jaffe H., et al. Characterization of the phosphorylation sites of human high molecular weight neurofilament protein by electrospray ionization tandem mass spectrometry and database searching. Biochemistry 1998, 37:3931-3940.
91. Veeranna K.T., et al. Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J. Neurochem. 1995, 64:2681-2690.
92. Rudrabhatla P., et al. Peptidyl-prolyl isomerase 1 regulates protein phosphatase 2A-mediated topographic phosphorylation of neurofilament proteins. J. Neurosci. 2009, 29:14869-14880.
93. Dougherty M.K., et al. Regulation of Raf-1 by direct feedback phosphorylation. Mol. Cell 2005, 17:215-224.
94. Xu Y.X., et al. Pin1 modulates the structure and function of human RNA polymerase II. Genes Dev. 2003, 17:2765-2776.
95. Xu Y.X., Manley J.L. The prolyl isomerase Pin1 functions in mitotic chromosome condensation. Mol. Cell 2007, 26:287-300.
96. Lu J., et al. A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. Carcinogenesis 2009, 30:1717-1721.
97. Segat L., et al. PIN1 promoter polymorphisms are associated with Alzheimer's disease. Neurobiol. Aging 2007, 28:69-74.
98. Ma S.L., et al. A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease. Neurobiol. Aging 2010, 10.1016/j.physletb.2003.10.071.
99. Lu K.P. Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem. Sci. 2004, 29:200-209.
100. Eckerdt F. Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J. Biol. Chem. 2005, 280:36575-36583.
101. Bialik S., Kimchi A. The death-associated protein kinases: structure, function, and beyond. Annu. Rev. Biochem. 2006, 75:189-210.
102. ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat. Cell Biol. 2001, 3:1-7.
103. Pan C.Q., et al. Active Mek2 as a regulatory scaffold that promotes Pin1 binding to BPGAP1 to suppress BPGAP1-induced acute Erk activation and cell migration. J. Cell Sci. 2010, 123:903-916.
104. Cohen M., et al. Trophoblastic p53 is stabilised by a cis-trans isomerisation necessary for the formation of high molecular weight complexes involving the N-terminus of p53. Biochimie 2008, 90:855-862.
105. Siepe D., Jentsch S. Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation. Nat. Cell Biol. 2009, 11:967-972.
106. Li Q.M., et al. Opposite regulation of oligodendrocyte apoptosis by JNK3 and Pin1 after spinal cord injury. J. Neurosci. 2007, 27:8395-8404.
107. Moretto-Zita M., et al. Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:13312-13317.
108. Nishi M., et al. A distinct role for Pin1 in the induction and maintenance of pluripotency. J. Biol. Chem. 2011, 286:11593-11603.
109. Jeong S.J., et al. The prolyl isomerase Pin1 stabilizes the human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein and promotes malignant transformation. Biochem. Biophys. Res. Commun. 2009, 381:294-299.
110. Manganaro L., et al. Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes. Nat. Med. 2010, 16:329-333.
111. Pang R., et al. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 2007, 132:1088-1103.
112. Monje P., et al. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J. Biol. Chem. 2005, 280:35081-35084.
113. Campaner S., et al. Sil phosphorylation in a Pin1 binding domain affects the duration of the spindle checkpoint. Mol. Cell. Biol. 2005, 25:6660-6672.
114. Proteau A., et al. The multifunctional nuclear protein p54nrb is multiphosphorylated in mitosis and interacts with the mitotic regulator Pin1. J. Mol. Biol. 2005, 346:1163-1172.
115. Esnault S., et al. The peptidyl-prolyl isomerase Pin1 regulates granulocyte-macrophage colony-stimulating factor mRNA stability in T lymphocytes. J. Immunol. 2006, 177:6999-7006.
116. EL signaling pathway in neuronal apoptosis. J. Neurosci. 2004, 24:8762-8770.
117. Cuvier O., et al. A topoisomerase II-dependent mechanism for resetting replicons at the S-M-phase transition. Genes Dev. 2008, 22:860-865.
118. Basu A., et al. Proteasomal degradation of human peptidyl prolyl isomerase pin1-pointing phospho Bcl2 toward dephosphorylation. Neoplasia 2002, 4:218-227.
119. Pathan N., et al. Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1. Neoplasia 2001, 3:550-559.
120. Lam P.B., et al. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability. Mol. Cancer 2008, 7:91.
121. Fujimoto Y., et al. Proline cis/trans-isomerase Pin1 regulates peroxisome proliferator-activated receptor γ activity through the direct binding to the activation function-1 domain. J. Biol. Chem. 2010, 285:3126-3132.
122. van der Horst A., Khanna K.K. The peptidyl-prolyl isomerase Pin1 regulates cytokinesis through Cep55. Cancer Res. 2009, 69:6651-6659.
123. Liao Y., et al. Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation. Oncogene 2009, 28:2436-2445.
124. Wang Y., et al. Pin1At encoding a peptidyl-prolyl cis/trans isomerase regulates flowering time in Arabidopsis. Mol. Cell 2010, 37:112-122.
125. Yu L., et al. Regulation of Bruton tyrosine kinase by the peptidylprolyl isomerase Pin1. J. Biol. Chem. 2006, 281:18201-18207.
126. Saitoh T., et al. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 2006, 7:598-605.
127. Stanya K.J., et al. Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT. J. Cell Biol. 2008, 183:49-61.
128. Ma J., et al. Negative regulation of Pim-1 protein kinase levels by the B56β subunit of PP2A. Oncogene 2007, 26:5145-5153.
129. kip1 expression through inhibition of Forkhead box O tumor suppressors. Cancer Res. 2008, 68:7597-7605.
130. Luo Z., et al. Pin1 facilitates the phosphorylation-dependent ubiquitination of SF-1 to regulate gonadotropin β-subunit gene transcription. Mol. Cell. Biol. 2010, 30:745-763.
131. Mitchell D.J., et al. Phosphorylation/dephosphorylation of human SULT4A1: role of Erk1 and PP2A. Biochim. Biophys. Acta 2011, 1813:231-237.
132. Mitchell D.J., Minchin R.F. Cytosolic aryl sulfotransferase 4A1 interacts with the peptidyl prolyl cis-trans isomerase Pin1. Mol. Pharmacol. 2009, 76:388-395.
133. Magli A., et al. Proline isomerase Pin1 represses terminal differentiation and myocyte enhancer factor 2C function in skeletal muscle cells. J. Biol. Chem. 2010, 285:34518-34527.
134. Ryo A., et al. A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx. J. Biol. Chem. 2007, 282:36671-36681.
135. Hamdane M., et al. Pin1 allows for differential Tau dephosphorylation in neuronal cells. Mol. Cell. Neurosci. 2006, 32:155-160.
136. Li M., et al. Binding of phosphatase inhibitor-2 to prolyl isomerase Pin1 modifies specificity for mitotic phosphoproteins. Biochemistry 2008, 47:292-300.
137. Shen Z.J., et al. Pin1 regulates TGF-β1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis. J. Clin. Invest. 2008, 118:479-490.
138. Nechama M., et al. The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism. J. Clin. Invest. 2009, 119:3102-3114.
139. Berger M., et al. Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage. Mol. Cell. Biol. 2005, 25:5380-5388.
140. Takahashi K., et al. Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1. Oncogene 2007, 26:3835-3845.
141. Toledo F., et al. Mouse mutants reveal that putative protein interaction sites in the p53 proline-rich domain are dispensable for tumor suppression. Mol. Cell. Biol. 2007, 27:1425-1432.
142. Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
143. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
144. Chambers I., et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113:643-655.